MSD Animal Health Announces New Leadership in EURAM Region

Robert Kelly brings deep expertise and knowledge of animal health industry

MADISON, N.J., May 9, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway,  N.J., USA (NYSE:MRK), announced today Robert (Rob) Kelly as the new leader of the company’s Europe, Russia, Africa and Middle East (EURAM) Region, beginning June 2022. Rob will be succeeding Dr. Hans Dittrich, who will be retiring later this year. Rob will be based in Dublin, Ireland.

“I am delighted to welcome Rob as the new leader of this important region, with his deep knowledge, business expertise, extensive animal health industry experience, as well as passion and commitment to animal health and well-being,” said Rick DeLuca, president, MSD Animal Health. “Rob has a proven track record of performance in the industry and is an advocate for animal health and agriculture, as well as building strong and productive teams. These will be assets that will help to strengthen and even expand our company’s presence in the EURAM region with our customers. Through our commitment to The Science of Healthier Animals®, we are dedicated to advancing the health and well-being of animals and the people who take care of them.”

“I am excited to be appointed to this new role, which has the ability to significantly impact the future of animal health in the EURAM region,” said Rob Kelly, lead of MSD Animal Health EURAM Region. “In this region, we are uniquely  positioned to capitalize on the evolving animal health biopharmaceutical and technology environment. We have a talented team, significant resources, as well as the solutions and technology to help our customers in the Livestock and Companion Animal markets. I look forward to getting to know the team and working with our veterinarians, farmers, producers and pet owners to shape the future of animal health and well-being.”

Rob comes to MSD Animal Health with over 20 years of global experience in the animal health industry, having held senior leadership roles in sales, marketing and commercial leadership.  Most recently, he was responsible for all markets outside of the United States for Zoetis. During his tenure at Zoetis, he also held leadership roles in the United States and Asia Pacific markets. He began his career in animal health with Schering-Plough, now known as MSD Animal Health, as a marketing manager and assumed roles of increasing responsibility at Fort Dodge Animal Health and, subsequently, Wyeth Animal Health.

Rob is a graduate of Western Sydney University in Australia with a bachelor’s degree in agriculture, and Macquarie Graduate School of Management, Australia with a master’s degree in marketing. 

About MSD Animal Health
At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business unit of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit and connect with us on LinkedIn and Twitter.